Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinomaMan Liu, John Wong, Philip Chun Yeung et al.|Gut|2019Cited by 182
A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinomaWeiqin Yang, Alfred S.L. Cheng, Yu Feng et al.|Science Translational Medicine|2021Cited by 167
Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liverWenshu Tang, Alfred S.L. Cheng, Jingying Zhou et al.|Cellular and Molecular Immunology|2022Cited by 112
An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinomaHanyong Sun, Alfred S.L. Cheng, Weiqin Yang et al.|Nature Communications|2018Cited by 94
Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesisYing‐Ying Lee, Alfred S.L. Cheng, Myth T.S. Mok et al.|Nucleic Acids Research|2018Cited by 67